Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
2015 · Ophthalmology · 204 citations
https://doi.org/10.1016/j.ophtha.2015.05.042
A
Andrew J. Barkmeier
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
2.2K
Citations
22
h-index
45
i10-index
Andrew J. Barkmeier is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal and Optic Conditions & Retinal Imaging and Analysis. The author has an h-index of 22, co-authored 106 publications.
ORCID: 0000-0002-2666-3828Papers by this author
worksThe Role of Systemic Risk Factors in Diabetic Retinopathy
2016 · Current Ophthalmology Reports · 41 citations
https://doi.org/10.1007/s40135-016-0098-8
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration
2023 · Ophthalmology Retina · 21 citations
https://doi.org/10.1016/j.oret.2023.10.012
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration
2023 · Ophthalmology Retina · 21 citations
https://doi.org/10.1016/j.oret.2023.10.012
Appropriateness of Ophthalmology Recommendations From an Online Chat-Based Artificial Intelligence Model
2024 · Mayo Clinic Proceedings Digital Health · 18 citations
https://doi.org/10.1016/j.mcpdig.2024.01.003
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
2024 · Ophthalmology Retina · 17 citations
https://doi.org/10.1016/j.oret.2024.05.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat